The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

Tinhofer I, Steurer M, Leitinger G, Rumpold H, Egle A, Erdel M, Greil R.

http://www.ncbi.nlm.nih.gov/pubmed/16956841